Skip to main content

Advertisement

SpringerLink
Log in

Active Paget’s disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Paget’s disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, skeletal deformities, and other complications leading to bone pain and significant disability. It can involve one or more areas in a single bone (monostotic) or multiple bones (polyostotic). Most of the time the disease is asymptomatic and the diagnosis is made incidentally by increased levels of bone metabolism markers, especially alkaline phosphatase and is confirmed by specific findings in radiographs and radionuclide bone scan. In this report, we describe the case of a 65-year-old female with clinical and radiological findings of active Paget’s disease of bone, but with absence of abnormal biochemical markers. The patient was given a dose of 5 mg zoledronic acid intravenously with significant clinical improvement within the next 6 months. The present case not only shows that Paget’s disease of bone can occur in the setting of normal markers of bone metabolism but also that, in such cases, the response to treatment can be monitored by improvement in the clinical picture or by correct evaluation of the imaging findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Paget J (1877) On a form of chronic inflammation of bones. Trans Med Chir Soc Lond 60:37–63

    Google Scholar 

  2. Siris ES, Lyles KW, Singer FR, Meunier PJ (2001) A clinical approach to diagnosis and management of Paget’s disease of bone. J Bone Miner Res 16:1379–1387

    Article  PubMed  Google Scholar 

  3. Kanis J (1998) Pathophysiology and treatment of Paget’s disease of bone, 2nd edn. Martin Dunitz, London

    Google Scholar 

  4. Altman R (2002) Paget’s disease of bone. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 985–1020

    Google Scholar 

  5. Doyle T, Gunn J, Anderson G, Gill M, Cundy T (2002) Paget’s disease in New Zealand: evidence for declining prevalence. Bone 31:616–619

    Article  CAS  PubMed  Google Scholar 

  6. Van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471

    Article  PubMed  Google Scholar 

  7. Cooper C, Dennison E, Schafheutle K, Kellingray S, Guyer P, Barker D (1999) Epidemiology of Paget’s disease of bone. Bone 24(5 Suppl):3S–5S

    Article  CAS  PubMed  Google Scholar 

  8. Siris ES (1996) Paget’s disease of bone. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd edn. Lippincott-Raven, Philadelphia, pp 409–419

    Google Scholar 

  9. Tiegs RD (1997) Paget’s disease of bone: indications for treatment and goals of therapy. Clin Ther 19:1309–1329

    Article  CAS  PubMed  Google Scholar 

  10. Davie M, Davies M, Francis R, Fraser W, Hosking D, Transley R (1999) Paget’s disease of bone: a review of 889 patients. Bone 24(5 Suppl):11S–12S

    Article  CAS  PubMed  Google Scholar 

  11. Hadjipavlou A, Lander P (1991) Paget’s disease of the spine. J Bone Joint Surg Am 73:1376–1381

    CAS  PubMed  Google Scholar 

  12. Barker DJ (1984) The epidemiology of Paget’s disease of bone. Br Med Bull 40:396–400

    CAS  PubMed  Google Scholar 

  13. Mee AP (1999) Paramyxoviruses and Paget’s disease: the affirmative view. Bone 24(5 Suppl):19S–21S

    Article  CAS  PubMed  Google Scholar 

  14. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Lenenstien MA, Shanks CA, Gregg G, Al-Lozi MT, Miller T, Rakowicz W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, Pestronk A, Kimonis VE (2001) Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone and frontotemporal dementia. Mol Genet Metab 74:458–475

    Article  CAS  PubMed  Google Scholar 

  15. Hocking L, Slee F, Haslam SI, Cundy T, Nicholson G, van Hul W, Ralston SH (2000) Familial Paget’s disease of bone: patterns of inheritance and frequency of linkage to chromosome 18 q. Bone 26:577–580

    Article  CAS  PubMed  Google Scholar 

  16. Whyte MP (2006) Paget’s disease of bone. NEJM 355:593–600

    Article  CAS  PubMed  Google Scholar 

  17. Helfrich MH, Hobson RP, Grabowski PS et al (2000) A negative search for a paramyxoviral etiology of Paget’s disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 15:2315–2329

    Article  CAS  PubMed  Google Scholar 

  18. Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnik CS, Gannon FH (2002) Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics 22:1191–1216

    PubMed  Google Scholar 

  19. Singh A, Rana K (2006) Paget’s disease with an unusual presentation: case report. Journal of the Indian Academy of Geriatrics 2(2):74–77

    Google Scholar 

  20. Alvarez L, Guanabens N, Penis P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Rivera-Fillat F, Ballesta AM (1995) Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget’s disease. J Bone Miner Res 10:458–465

    Article  CAS  PubMed  Google Scholar 

  21. Selby PL, Davie MWJ, Ralston H et al (2002) Guidelines on the management of Paget’s disease of bone. Bone 31:10–19

    Article  Google Scholar 

  22. Shankar S, Hosking DJ (2006) Biochemical assessment of Paget’s disease of bone. J Bone Miner Res 21(Suppl2):P22–P27

    Article  CAS  PubMed  Google Scholar 

  23. Sinigaglia L, Varenna M, Binelli L, Beltrametti P, Yucchi F, Arrigoni M, Frignani S, Abbiati G (1997) Serum levels of pyridinium crosslinks in postmenopausal women and in Paget’s disease of bone. Calcif Tissue Int 61:279–284

    Article  CAS  PubMed  Google Scholar 

  24. Uebelhart D, Gineyts E, Chapuy M, Delmas PD (1990) Urinary excretion of pyridinium crosslinks: anew marker of bone resorption in metabolic bone disease. Bone Miner 8:87–96

    Article  CAS  PubMed  Google Scholar 

  25. Fogelman I, Carr D, Boyle IT (1981) The role of bone scanning in Paget’s disease. Metab Bone Dis Relat Res 3:243–254

    Article  CAS  PubMed  Google Scholar 

  26. Smith R (1999) Paget’s disease of bone: past and present. Bone 24(5 Suppl):1S–2S

    Article  CAS  PubMed  Google Scholar 

  27. Seton M, Krane S (2007) Use of zoledronic acid in the treatment of Paget’s disease. Ther Clin Risk Manag 3(5):913–918

    CAS  PubMed  Google Scholar 

  28. Fleisch H (2002) Development of biphosphonates. Breast Cancer Res 4:30–34

    Article  CAS  PubMed  Google Scholar 

  29. Hosking D (2006) Pharmacological therapy of Paget’s and other metabolic bone diseases. Bone 38(2 Suppl 2):S3–S7

    Article  CAS  PubMed  Google Scholar 

  30. Widler L, Jaeggi KA, Glatt M et al (2002) Highly potent geminal biphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). J Med Chem 45:3721–3738

    Article  CAS  PubMed  Google Scholar 

  31. Buckler H, Fraser W, Hosking D et al (1999) Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study. Bone 24:81S–85S

    Article  CAS  PubMed  Google Scholar 

  32. Chung G, Keen RW (2003) Zoledronate treatment in active Paget’s disease. Ann Rheum Dis 62:275–276

    Article  CAS  PubMed  Google Scholar 

  33. Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR (2007) Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. J Bone Miner Res 22(1):142–148

    Article  CAS  PubMed  Google Scholar 

  34. Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH (2007) Clinical determinants of quality of life in Paget’s disease of bone. Calcif Tissue Int 80(1):1–9

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Endocrinology, University Hospital of Ioannina, Dim. Hatzi 68, Ioannina, 45445, Greece

    Lamprini Gkouva, Maria Andrikoula & Agathocles Tsatsoulis

  2. Department of Orthopaedics, General Hospital of Volos, Volos, Greece

    Vasilis Kontogeorgakos

  3. Department of Histology and Embryology, University of Patras, School of Medicine, Patras, Greece

    Dionysios J. Papachristou

  4. Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA

    Dionysios J. Papachristou

Authors
  1. Lamprini Gkouva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Andrikoula
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vasilis Kontogeorgakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dionysios J. Papachristou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Agathocles Tsatsoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Andrikoula.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gkouva, L., Andrikoula, M., Kontogeorgakos, V. et al. Active Paget’s disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature. Clin Rheumatol 30, 139–144 (2011). https://doi.org/10.1007/s10067-010-1579-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1579-z

Keywords

Search

Navigation